1. Xu, Xiaowei, Hua, Xu, Brown, Kyle, Ren, Xiaojun, Zhang, Zhiguo. 2022. Mcm2 promotes stem cell differentiation via its ability to bind H3-H4. In eLife, 11, . doi:10.7554/eLife.80917. https://pubmed.ncbi.nlm.nih.gov/36354740/
2. Liu, Sainan, Liang, Zhuoshuai, Wang, Yujian, Cheng, Yi, Liu, Yawen. . MCM2 is involved in subtyping and tamoxifen resistance of ERα-positive breast cancer by acting as the downstream factor of ERα. In Biotechnology journal, 19, e2300560. doi:10.1002/biot.202300560. https://pubmed.ncbi.nlm.nih.gov/38403459/
3. Lv, Huina, Du, Yang, Xin, Peng, Liu, Zhe, Jing, Yuchen. 2024. Identification of prevention marker associated with DNA replication in ovarian cancer: Expression of MCM2 protein and bioinformatics analysis. In International journal of biological macromolecules, 279, 135079. doi:10.1016/j.ijbiomac.2024.135079. https://pubmed.ncbi.nlm.nih.gov/39187104/
4. Jia, Wei, Wang, Chao. 2023. KNTC1 and MCM2 are the molecular targets of gallbladder cancer. In Aging, 15, 7008-7022. doi:10.18632/aging.204889. https://pubmed.ncbi.nlm.nih.gov/37480569/
5. Nasri Nasrabadi, Parinaz, Nayeri, Zahra, Gharib, Ehsan, Mahjoubi, Forouzandeh, Zomorodipour, Alireza. 2020. Establishment of a CALU, AURKA, and MCM2 gene panel for discrimination of metastasis from primary colon and lung cancers. In PloS one, 15, e0233717. doi:10.1371/journal.pone.0233717. https://pubmed.ncbi.nlm.nih.gov/32469983/